Back to basics: the ABCs of disruptive technologies and antitrust and competition law
Author: Sandy Aziz (Norton Rose Fulbright LLP) Europe’s competition law climate is weathered by fear and speculation regarding the dangers of technologies, which despite not being newly discovered, are described as “disruptive” because they’ve overturned conventional business models. Not only is there a lot we don’t know about these “disruptive” technologies, but some individuals have gone further to refer to the companies developing these technologies as “BADD” – big, antico
Pharmaceutical pricing—is antitrust the right tool for the job?
Author: Dr Avantika Chowdhury, Principal, Oxera Disclaimer: the views expressed in this article are only those of the author, and do not represent the views of any associated organisation. The recent focus on ‘fairness’ in competition law and policy circles has brought a wave of excessive pricing cases in Europe, many of which are in the pharmaceutical sector. This short blog post discusses: the key commonality across the cases, and in particular, the importance of entry barr
